Anticardiolipin and Anti-Beta₂ Glycoprotein I Antibodies in Infants Born to Mothers with Antiphospholipid Antibody-Positive Autoimmune Disease: A Follow-Up Study

 

 Buy Article Permissions and Reprints

ABSTRACT

Infants born from mothers with antiphospholipid antibody (aPL) -positive autoimmune disease were prospectively evaluated for anticardiolipin and anti-β2 glycoprotein I antibodies (group 1) and for growth and neurological development. The results were compared with those obtained from two age-matched control groups (group 2 and 3). All infants were negative for anticardiolipin at 12 months of life, whereas 14 (63.6%), eight (33.3%), and 10 (55.5%) of infants from group 1, 2, and 3, respectively, were positive for anti-beta₂ glycoprotein I. At follow-up, all infants had normal growth and neurological development. No thrombotic complication was observed. The negativity of anticardiolipin in all infants at 12 months suggests that anticardiolipin detection is the best assay to evaluate the disappearance of maternal aPL and to estimate the potential risk of thrombosis associated with these antibodies. The high rate of anti-beta₂ glycoprotein I positivity in all three groups of infants may indicate that the synthesis of this antibody is stimulated by aspecific factors.

REFERENCES

• 1 Hughes G RV, Harris E N, Gharavi A E. The anticardiolipin syndrome.  J Rheumatol. 1986;  13 486-489
  PubMedGoogle Scholar
• 2 Wilson W A, Gharavi A E, Koike T et al.. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.  Arthritis Rheum. 1999;  42 1309-1311
  CrossrefPubMedGoogle Scholar
• 3 Pangborn M C. A new serologically active phospholipid from beef heart.  Proc Soc Exp Biol Med. 1941;  48 484-486
  CrossrefPubMedGoogle Scholar
• 4 McNeil H P, Simpson R J, Chesterman C N, Krilis S A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipidbinding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H).  Proc Natl Acad Sci USA. 1990;  87 4120-4124
  CrossrefPubMedGoogle Scholar
• 5 Galli M, Comfurius P, Maassen C et al.. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.  Lancet. 1990;  335 1544-1547
  CrossrefPubMedGoogle Scholar
• 6 Matsuura E, Igarashi Y, Fujimoto M et al.. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.  Lancet. 1990;  336 177-178
  PubMedGoogle Scholar
• 7 Galli M, Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome.  Blood. 1999;  93 2149-2157
  PubMedGoogle Scholar
• 8 Balestrieri G, Tincani A, Spatola L et al.. Anti-β2- glycoprotein I antibodies: a marker of antiphospholipid syndrome?.  Lupus. 1995;  4 122-130
  CrossrefPubMedGoogle Scholar
• 9 Viard J-P, Amoura Z, Bach J-F. Association of anti-b2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.  Am J Med. 1992;  93 181-186
  CrossrefPubMedGoogle Scholar
• 10 Cabral A R, Amigo M C, Cabiedes J, Alarcón-Segovia D. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to β2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.  Am J Med. 1996;  101 472-481
  CrossrefPubMedGoogle Scholar
• 11 Carreras L O, Forastiero R R, Martinuzzo M E. Which are the best biological markers of the antiphospholipid syndrome?.  J Autoimmun. 2000;  15 163-172
  CrossrefPubMedGoogle Scholar
• 12 Miyakis S, Lockshin M D, Atsumi T et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).  J Thromb Haemost. 2006;  4 295-306
  CrossrefPubMedGoogle Scholar
• 13 Branch D W, Khamashta M A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.  Obstet Gynecol. 2003;  101 1333-1344
  CrossrefPubMedGoogle Scholar
• 14 Pollard J K, Scott J R, Branch D W. Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome.  Obstet Gynecol. 1992;  80 365-368
  PubMedGoogle Scholar
• 15 Botet F, Romera G, Montagut P, Figueras J, Carmona F, Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.  J Perinat Med. 1997;  25 192-196
  PubMedGoogle Scholar
• 16 Ruffatti A, Dalla Barba B, Del Ross T et al.. Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy.  Clin Exp Rheumatol. 1998;  16 605-610
  PubMedGoogle Scholar
• 17 Brewster J A, Shaw N J, Farquharson R G. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome.  J Perinat Med. 1999;  27 183-187
  CrossrefPubMedGoogle Scholar
• 18 Tincani A, Lojacono A, Taglietti M et al.. Pregnancy and neonatal outcome in primary antiphospholipid syndrome.  Lupus. 2002;  11 649
  CrossrefPubMedGoogle Scholar
• 19 Finazzi G, Cortelazzo S, Viero P, Galli M, Barbui T. Maternal lupus anticoagulant and fatal neonatal thrombosis.  Thromb Haemost. 1987;  57 238
  PubMedGoogle Scholar
• 20 Sheridan-Pereira M, Porreco R P, Hays T, Burke M S. Neonatal aortic thrombosis associated with the lupus anticoagulant.  Obstet Gynecol. 1988;  71 1016-1018
  PubMedGoogle Scholar
• 21 Silver R K, Mac Gregor S N, Pasternak J F, Neely S E. Fetal stroke associated with elevated maternal anticardiolipin antibodies.  Obstet Gynecol. 1992;  80 497-499
  PubMedGoogle Scholar
• 22 Contractor S, Hiatt M, Kosmin M, Kim H C. Neonatal thrombosis with anticardiolipin antibody in baby and mother.  Am J Perinatol. 1992;  9 409-410
  PubMedGoogle Scholar
• 23 Tabbutt S, Griswold W R, Ogino M T, Mendoza A E, Allen J B, Reznik V M. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome.  J Perinatol. 1994;  14 66-70
  PubMedGoogle Scholar
• 24 Hage M L, Liu R, Marcheschi D G, Bowie J D, Allen N B, Macik B G. Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant: a case report.  Prenat Diagn. 1994;  14 873-877
  PubMedGoogle Scholar
• 25 Teyssier G, Gautheron V, Absi L, Galambrun C, Ravni C, Lepetit J C. Anticorps anticardiolipine, ischémie cérébrale et hémorragie surrénalienne chez un nouveau-né.  Arch Pediatr. 1995;  2 1086-1088
  CrossrefPubMedGoogle Scholar
• 26 de Klerk O L, de Vries T W, Sinnige L GF. An unusual cause of neonatal seizures in a newborn infant.  Pediatrics. 1997;  100 E8
  PubMedGoogle Scholar
• 27 Navarro F, Dona-Naranjo M A, Villanueva I. Neonatal antiphospholipid syndrome.  J Rheumatol. 1997;  24 1240-1241
  PubMedGoogle Scholar
• 28 Akanli L F, Trasi S S, Thuraisamy K et al.. Neonatal middle cerebral artery infarction: association with elevated maternal anticardiolipin antibodies.  Am J Perinatol. 1998;  15 399-402
  PubMedGoogle Scholar
• 29 Chow G, Mellor D. Neonatal cerebral ischemia with elevated maternal and infant anticardiolipin antibodies.  Dev Med Child Neurol. 2000;  42 412-413
  CrossrefPubMedGoogle Scholar
• 30 Tincani A, Allegri F, Sanmarco M et al.. Anticardiolipin antibody assay-a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum.  Thromb Haemost. 2001;  86 575-583
  PubMedGoogle Scholar
• 31 Balestrieri G, Tincani A, Spatola L et al.. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?.  Lupus. 1995;  4 122-130
  CrossrefPubMedGoogle Scholar
• 32 Capute A J, Shapiro B K. The motor quotient: a method for early determination of motor delay.  Am J Dis Child. 1985;  139 940-942
  PubMedGoogle Scholar
• 33 Zurgil N, Bakimer R, Tincani A et al.. Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE.  Lupus. 1993;  2 233-237
  PubMedGoogle Scholar
• 34 Cohen S B, Goldenberg M, Rabinovici J et al.. Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome.  Hum Reprod. 2000;  15 1170-1172
  CrossrefPubMedGoogle Scholar
• 35 Chamley L W, Allen J L, Johnson P M. Synthesis of β2-glycoprotein 1 by the human placenta.  Placenta. 1997;  18 403-407
  CrossrefPubMedGoogle Scholar
• 36 Fialová L, Malbohan I, Mikulíková L, Benešová O, Zwinger A. Antibodies against β2-glycoprotein I (β2-GP I) and their relationship to fetoplacental antigens.  Physiol Res. 2002;  51 449-455
  PubMedGoogle Scholar
• 37 di Simone N, Meroni P L, Del Papa N et al.. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.  Arthritis Rheum. 2000;  43 140-150
  CrossrefPubMedGoogle Scholar
• 38 Avcin T, Cimaz R, Meroni P L. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.  Lupus. 2002;  11 4-10
  CrossrefPubMedGoogle Scholar
• 39 Avcin T, Ambrozic A, Kuhar M, Kveder T, Rozman B. Anticardiolipin and anti-β2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits.  Rheumatology (Oxford). 2001;  40 565-573
  CrossrefPubMedGoogle Scholar
• 40 Shoenfeld Y, Krause I, Kvapil F et al.. Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.  J Clin Immunol. 2003;  23 377-383
  CrossrefPubMedGoogle Scholar

1 Deceased

Mario MottaM.D. 

Division of Neonatology and Neonatal Intensive Care

Spedali Civili, 25123 Brescia, Italy